Literature DB >> 17660716

MicroRNA with a MacroFunction.

Shweta Rane1, Danis Sayed, Maha Abdellatif.   

Abstract

With the advent of microRNA (miRNA) we are compelled to revise our understanding of the mechanisms underlying gene regulation during health and disease. A miRNA is approximately 21 ribonucleotides-long, genetically encoded, with a potential to recognize multiple mRNA targets guided by sequence complementarity and RNA-binding proteins. This class of molecules is functionally versatile, with the capacity to specifically inhibit translation initiation or elongation, as well as, induce mRNA degradation, through predominantly targeting the 3'-untranslated regions of mRNA. Early on it was realized that the levels of individual miRNA varied under different developmental, biological, or pathological conditions, thus, implicating these molecules in normal and pathological cellular attributes. In this article we will share our views on how the functions of miRNA conform to our existing knowledge on post-transcriptional regulation of gene expression and disease mechanisms, and their potential as biomarkers and therapeutic targets in diseases.

Mesh:

Substances:

Year:  2007        PMID: 17660716     DOI: 10.4161/cc.6.15.4551

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

1.  Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function.

Authors:  Ha Won Kim; Shujia Jiang; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  J Mol Med (Berl)       Date:  2012-05-31       Impact factor: 4.599

2.  Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8.

Authors:  Sharmistha Bhattacharyya; Nagaraja S Balakathiresan; Clifton Dalgard; Usha Gutti; David Armistead; Cathy Jozwik; Meera Srivastava; Harvey B Pollard; Roopa Biswas
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

Review 3.  MicroRNA-155: A Master Regulator of Inflammation.

Authors:  Guruswamy Mahesh; Roopa Biswas
Journal:  J Interferon Cytokine Res       Date:  2019-03-20       Impact factor: 2.607

4.  GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy.

Authors:  Mingyue Han; Zhi Yang; Danish Sayed; Minzhen He; Shumin Gao; Lin Lin; Seonghun Yoon; Maha Abdellatif
Journal:  Cardiovasc Res       Date:  2012-01-04       Impact factor: 10.787

Review 5.  Differential expression of microRNAs in different disease states.

Authors:  Maha Abdellatif
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

Review 6.  miRNAs as biomarkers for management of patients with colorectal cancer.

Authors:  Upender Manne; Chandrakumar Shanmugam; Liselle Bovell; Venkat R Katkoori; Harvey L Bumpers
Journal:  Biomark Med       Date:  2010-10       Impact factor: 2.851

Review 7.  MicroRNAs in cholangiociliopathies.

Authors:  Tatyana Masyuk; Anatoliy Masyuk; Nicholas LaRusso
Journal:  Cell Cycle       Date:  2009-05-23       Impact factor: 4.534

8.  MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts.

Authors:  Khawaja Husnain Haider; Niagara Muhammad Idris; Ha Won Kim; Rafeeq P H Ahmed; Jiang Shujia; Muhammad Ashraf
Journal:  Cardiovasc Res       Date:  2010-05-24       Impact factor: 10.787

9.  Regulating the Regulators: microRNA and Asthma.

Authors:  Jia-Wang Wang; Kunyu Li; Gary Hellermann; Richard F Lockey; Subhra Mohapatra; Shyam Mohapatra
Journal:  World Allergy Organ J       Date:  2011-06       Impact factor: 4.084

10.  Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms.

Authors:  Manuel Comabella; David W Craig; Montse Camiña-Tato; Carlos Morcillo; Cristina Lopez; Arcadi Navarro; Jordi Rio; Xavier Montalban; Roland Martin
Journal:  PLoS One       Date:  2008-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.